JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

Search

ResMed Inc

Fechado

SetorSaúde

218.81 -1.18

Visão Geral

Variação de preço das ações

24h

Atual

Mín

216.2

Máximo

221.52

Indicadores-chave

By Trading Economics

Rendimento

44M

393M

Vendas

87M

1.4B

P/E

Médio do Setor

22.368

60.328

Rendimento de Dividendos

0.99

Margem de lucro

27.593

Funcionários

10,600

EBITDA

63M

566M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+29.12% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.99%

2.24%

Próximos Ganhos

30 de abr. de 2026

Próxima data de dividendos

11 de jun. de 2026

Próxima data de ex-dividendo

7 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-4.3B

33B

Abertura anterior

219.99

Fecho anterior

218.81

Sentimento de Notícias

By Acuity

49%

51%

176 / 348 Ranking em Healthcare

ResMed Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

24 de abr. de 2026, 00:00 UTC

Ganhos

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

24 de abr. de 2026, 00:00 UTC

Ganhos

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

23 de abr. de 2026, 23:47 UTC

Conversa de Mercado

Gold Edges Lower Amid Ongoing Concerns Over Higher Inflation -- Market Talk

23 de abr. de 2026, 23:43 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

23 de abr. de 2026, 23:43 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

23 de abr. de 2026, 23:43 UTC

Conversa de Mercado

Nikkei May Decline Amid Uncertainty Over U.S.-Iran Conflict -- Market Talk

23 de abr. de 2026, 23:13 UTC

Aquisições, Fusões, Aquisições de Empresas

Trump on Spirit Airlines: 'I Think We'd Just Buy It' -- Update

23 de abr. de 2026, 22:33 UTC

Ganhos

Intel Shares Jump 20% as AI Agents Drive Big Growth -- WSJ

23 de abr. de 2026, 22:17 UTC

Ganhos

PLS Executed Offtake Agreement With Ronbay

23 de abr. de 2026, 22:17 UTC

Ganhos

PLS Secured Up to A$38.1M in Australia Government ARENA Grant Funding

23 de abr. de 2026, 22:16 UTC

Ganhos

PLS Commences Commissioning of Midstream Demonstration Plant

23 de abr. de 2026, 22:15 UTC

Ganhos

PLS Group Reaffirms FY26 Guidance for All Metrics

23 de abr. de 2026, 22:14 UTC

Ganhos

PLS Group 3Q Cash Margin From Operations A$461M at March 31

23 de abr. de 2026, 22:14 UTC

Ganhos

PLS Group 3Q Cash Balance A$1.455 Billion at March 31

23 de abr. de 2026, 22:13 UTC

Ganhos

PLS Group 3Q Unit Operating Cost A$733/Ton CIF, Up 2% on 2Q

23 de abr. de 2026, 22:12 UTC

Ganhos

Correct: PLS Group 3Q Unit Operating Cost A$520/Ton FOB, Down 11% on 2Q

23 de abr. de 2026, 22:12 UTC

Ganhos

PLS Group 3Q Unit Operating Cost US$520/Ton FOB, Down 11% on 2Q

23 de abr. de 2026, 22:11 UTC

Ganhos

PLS Group 3Q Realized Price US$1,867/Ton, Up 61% on 2Q

23 de abr. de 2026, 22:10 UTC

Ganhos

PLS Group 3Q Revenue A$567,000, Up 52% on 2Q

23 de abr. de 2026, 22:09 UTC

Ganhos

PLS Group 3Q Sales 195,700 Tons, Down 16% on 2Q

23 de abr. de 2026, 22:08 UTC

Ganhos

PLS Group 3Q Production 232,400 Tons, Up 12% on 2Q

23 de abr. de 2026, 22:04 UTC

Ganhos

Intel Sales Rise 7% as AI Agents Drive Growth -- WSJ

23 de abr. de 2026, 21:56 UTC

Conversa de Mercado
Ganhos

Intel Points to Growing Role of CPUs Amid AI Shifts -- Market Talk

23 de abr. de 2026, 21:48 UTC

Aquisições, Fusões, Aquisições de Empresas

Regeneron Shares Up on Trump Drug Pricing Deal -- Barrons.com

23 de abr. de 2026, 21:27 UTC

Ganhos

Intel CFO: All Demand Signals Point to Growing Role of CPUs in AI Era

23 de abr. de 2026, 21:25 UTC

Ganhos

Intel CFO Expects Factories to Continue Increasing Supply in 3Q, 4Q, but at More Measured Pace Than Previously Expected

23 de abr. de 2026, 21:24 UTC

Ganhos

SAP Stock Rebounds From Software Slaughter. The Cloud Boosted Europe's Tech Titan. -- Barrons.com

23 de abr. de 2026, 21:24 UTC

Ganhos

Blackstone Stock Falls After Earnings. Private Credit Remains in Focus. -- Barrons.com

23 de abr. de 2026, 21:21 UTC

Ganhos

Intel to Look for Unconventional Way to Boost Manufacturing Capacity Through Musk's Terafab Project, CEO Says

23 de abr. de 2026, 21:21 UTC

Ganhos

Intel CEO: He, Elon Musk Believe Global Semiconductor Supply Isn't Keeping Up With Accelerating Demand

Comparação entre Pares

Variação de preço

ResMed Inc Previsão

Preço-alvo

By TipRanks

29.12% parte superior

Previsão para 12 meses

Média 286.7 USD  29.12%

Máximo 340 USD

Mínimo 255 USD

Com base em 13 analistas de Wall Street que oferecem metas de preço de 12 meses para ResMed Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

13 ratings

8

Comprar

5

Manter

0

Vender

Sentimento

By Acuity

176 / 348 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat